Tris Pharma Announces Development of a Very Low Sodium and Once-Nightly Oxybate Formulation

/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a fully integrated pharmaceutical company with a robust portfolio of CNS products announced today that it has...

Related Keywords

Minnesota ,United States ,King County ,Washington ,Olmsted County ,Ketan Mehta ,International Classification Of Sleep Disorders ,Tris Pharma Inc ,Prnewswire Tris Pharma Inc ,Jazz Pharmaceuticals ,Jazz Pharmaceutical ,Orphan Drug Designation ,Chief Executive Officer ,Current Management Strategies ,Future Prospects ,Overlooked Real Life ,Anat Sci ,International Classification ,Clin Sleep ,Tris Pharma ,Nc ,